Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v1-EN
Language French English
Date Updated 2020-03-23 2017-06-12
Drug Identification Number 00627100 00627100
Brand name DILAUDID DILAUDID
Common or Proper name Hydromorphone Hydrochloride, 2mg/mL Dilaudid 2mg/mL
Company Name PURDUE PHARMA PURDUE PHARMA
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 2MG 2MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 25 x 1 mL ampoules 25 x 1 mL ampoules
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-06-12 2017-06-12
Actual start date 2017-06-12 2017-06-12
Estimated end date 2017-12-31 2017-12-31
Actual end date 2017-12-31
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Inventory constraints Inventory constraints
Health Canada comments